Richard Beigi
Overview
Explore the profile of Richard Beigi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munoz F, Beigi R, Posavad C, Kelly C, Badell M, Bunge K, et al.
Pediatr Infect Dis J
. 2025 Jan;
43(11):1065-1073.
PMID: 39774938
Background: Following maternal COVID-19 vaccination, the persistence of antibodies in sera and breast milk for mothers and infants is not well characterized. We sought to describe the persistence of antibodies...
2.
Rick A, Beigi R
Clin Obstet Gynecol
. 2024 Jun;
67(3):605-619.
PMID: 38899806
Maternal vaccines during pregnancy offer crucial protection against infections for both the pregnant person and their newborn. Vaccines against influenza, pertussis, coronavirus disease 2019, and respiratory syncytial virus are routinely...
3.
Cardemil C, Cao Y, Posavad C, Badell M, Bunge K, Mulligan M, et al.
Pediatrics
. 2024 Feb;
153(3).
PMID: 38332733
Background And Objectives: Maternal vaccination may prevent infant coronavirus disease 2019 (COVID-19). We aimed to quantify protection against infection from maternally derived vaccine-induced antibodies in the first 6 months of...
4.
Rick A, Copp E, Buckley A, Yanowitz T, Martin J, Shaikh N, et al.
Res Sq
. 2023 Aug;
PMID: 37577707
Objective: To determine test characteristics of categorical risk stratification for early onset sepsis (EOS) using maternal criteria for suspected intraamniotic infection (IAI) and/or newborn exam and compare them to the...
5.
Munoz F, Posavad C, Richardson B, Badell M, Bunge K, Mulligan M, et al.
medRxiv
. 2022 Jun;
PMID: 35734087
Importance: COVID-19 vaccination is recommended during pregnancy for the protection of the mother. Little is known about the immune response to booster vaccinations during pregnancy. Objective: To measure immune responses...
6.
Lokken E, Mathur A, Bunge K, Fairlie L, Makanani B, Beigi R, et al.
Front Reprod Health
. 2022 Feb;
3.
PMID: 35187529
Background: Robust data summarizing the prevalence of pregnancy and neonatal outcomes in low- and middle-income countries are critically important for studies evaluating investigational products for HIV prevention and treatment in...
7.
Lyerly A, Beigi R, Bekker L, Chi B, Cohn S, Diallo D, et al.
J Int AIDS Soc
. 2021 Dec;
24(12):e25846.
PMID: 34910846
Introduction: While pregnant people have been an important focus for HIV research, critical evidence gaps remain regarding prevention, co-infection, and safety and efficacy of new antiretroviral therapies in pregnancy. Such...
8.
Austin M, Meyn L, Avolia H, Petrina M, Cosentino L, Alphonse C, et al.
J Infect Dis
. 2021 Dec;
225(12):2208-2218.
PMID: 34865071
Background: A 25-mg dapivirine vaginal ring has been demonstrated to reduce risk of human immunodeficiency virus (HIV) acquisition in nonpregnant adult women. In this secondary analysis of studies conducted in...
9.
Hillier S, Austin M, Macio I, Meyn L, Badway D, Beigi R
Clin Infect Dis
. 2020 May;
72(9):1538-1543.
PMID: 32350529
Background: Although vaginal symptoms are common, diagnosis of bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and Trichomonas vaginalis (TV) is not standardized. Diagnostic approaches and appropriateness of treatment were evaluated for...
10.
Montgomery E, Roberts S, Nel A, Malherbe M, Torjesen K, Bunge K, et al.
AIDS
. 2019 Aug;
33(14):2237-2244.
PMID: 31408030
Objectives: Assessment of safety is an integral part of real-time monitoring in clinical trials. In HIV prevention research, safety of investigational products and trial participation has been expanded to include...